LUNG BASIC PANEL BY NGS IHC & FRAGMENT ANALYSIS PCR PDL1 IHC & MSI PCR(O.S.)

Overview

This lung cancer panel is a high throughput next-generation sequencing based single assay that may provide treatment benefit to the patients. This next-generation sequencing based multi-gene lung cancer test is developed to sequence and identify genomic alterations associated with genes having therapeutic, prognostic and diagnostic implications. This panel covers key lung cancer genes for the assessment of various classes of genomic alterations (SNVs, InDels, CNVs and Fusions). MET gene is primarily tested for variations that lead to exon 14 skipping.